- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- Join Join
In an historic move, the American Herbal Pharmacopoeia (AHP) released the first installation of a two-part Cannabis monograph today that classifies cannabis (marijuana) as a botanical medicine, alongside many other widely accepted Complementary and Alternative Medicines. The monograph, entitled Standards of Identity, Quality, and Testing, will be followed late this spring by the Therapeutic Compendium. This is important for the patients, doctors, and researchers, all of whom will benefit from having proven testing standards that can quantify the key cannabinoids that affect therapeutic effects, as well as identify potentially harmful pesticides, metals, and microbes.
Members of Americans for Safe Access (ASA) helped get this monograph published because we want to see cannabis treated like other herbal medicines by doctors, researchers, and regulators. We look forward to a time when everyone who needs medical cannabis has safe and dignified access. The monograph is a big part of that effort.
Our members have been the backbone behind the amazing work ASA has been able to accomplish, but we still have a long way to go. Please consider becoming a member of ASA today to help us do this kind of long-term, big picture work that will finally bring medical cannabis back into the mainstream of herbal medicine for everyone.
Later this week, ASA will launch Patient Focused Certification (PFC), an innovative new program that will calibrate the medical cannabis industry for excellence. As a third-party certification program for the medical cannabis industry, PFC is based on the AHP Cannabis monograph and new quality standards for medical cannabis products and businesses issued by the American Herbal Products Association (AHPA). Want to learn more about PFC and how the cannabis monograph will help ensure quality assurance for the future?
Join us for a live Google Hangout this Thursday, December 12th at 5:30pm PST/ 8:30pm EST to hear from a panel of experts including AHP Executive Director Roy Upton, RH, DAyu; Professor Lyle Craker, PhD, of University of Massachusetts Amherst; and Dr. Michelle Sexton, ND, and Dr. Jahan Marcu, PhD, of the Americans for Safe Access Multidisciplinary Scientific Advisory Board on the significance of the Cannabis monograph and the new PFC certification program.
What: Live Google Hangout
When: Thursday, December 12, 2013 at 5:30PST / 8:30PM EST
Why: To hear from a panel of a panel of experts discussing the ramifications of the Cannabis monograph and a new Cannabis certification program.